Treatment strategies for complex behavioral insomnia in children with neurodevelopmental disorders

Madeleine Grigg-Damberger1, Frank Ralls

  • 1aDepartment of Neurology, University of New Mexico School of Medicine bPediatric Sleep Medicine Services, University Hospital Sleep Disorders Center cClinical Neurodiagnostic Laboratory, University of New Mexico Medical Center dDepartment of Internal Medicine eAdult Sleep Medicine Services fProgram in Sleep Medicine, University of New Mexico Hospital Sleep Disorders Center, Albuquerque, New Mexico, USA.

Insights

Pediatric behavioral insomnias in neurodevelopmental disorders (NDDs) are complex and chronic. Behavioral therapies and melatonin offer benefits for treating sleep problems in children with NDDs.

Area of Science:

  • Pediatric sleep medicine
  • Neurodevelopmental disorders
  • Behavioral psychology

Background:

  • Insomnia is prevalent and challenging in children with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs).
  • Genetic and epigenetic factors contribute to sleep-wake regulation abnormalities in NDDs.
  • Poor sleep hygiene, maladaptive associations, and limit-setting issues exacerbate sleep problems.

Purpose of the Study:

  • To review recent research on pediatric behavioral insomnias in neurodevelopmental disorders.
  • To discuss current treatment strategies for sleep problems in this population.

Main Methods:

  • Literature review of recent research.
  • Synthesis of findings on the etiology and treatment of pediatric insomnia in NDDs.

Main Results:

  • Sleep problems in children with NDDs are complex, chronic, and difficult to manage.
  • Behavioral therapies and melatonin are beneficial for treating sleep issues.
  • Sleep disturbances are integral to the diagnostic criteria for certain neurodevelopmental syndromes.

Conclusions:

  • Children and adolescents with neurological disorders often experience complex sleep disorders requiring intervention.
  • Understanding the underlying pathology and treatment options can improve the quality of life for affected children and their families.
Abstract

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...